BMJ  2007;334:671-673 (31 March), doi:10.1136/bmj.39140.623137.BE

Analysis

Towards sustainable clinical trials

Currently, few researchers think about the carbon footprint of their trial. The Sustainable Trials Study Group reports that clinical trials are carbon intensive and suggests ways to make them more efficient

The first 150 words of the full text of this article appear below.

Greenhouse gases are changing the global climate, with serious implications for health and ecosystems.^{1 2} All sectors of the economy, including the health sector, must act to reduce greenhouse gas emissions.³ High income countries need to cut emissions by about 90% by 2030 to limit the global average increase in temperature to 2°C, and thus reduce the risk of the most serious consequences.⁴

The Sustainable Trials Study Group was convened by the London School of Hygiene & Tropical Medicine to find ways of reducing greenhouse gas emissions from clinical trials. This international health research institution has an extensive research programme on the links between environment and health. A sustainability group was established to reduce the institution's carbon footprint, and this study is a product of its work.

Clinical trials contribute substantially to greenhouse gas emissions The main sources are energy use in research premises and air travel Renewable energy sources and . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials

Katy Lyle, Louise Dent, Sally Bailey, Lynn Kerridge, Ian Roberts, and Ruairidh Milne
BMJ 2009 339: b4187. [Abstract] [Full Text] [PDF]

Global environmental change and health: impacts, inequalities, and the health sector

A J McMichael, S Friel, A Nyong, and C Corvalan
BMJ 2008 336: 191-194. [Extract] [Full Text] [PDF]

What should we do about climate change?: Health professionals need to act now, collectively and individually

Robin Stott and Fiona Godlee
BMJ 2006 333: 983-984. [Extract] [Full Text] [PDF]

Bureaucracy of ethics applications

David S Wald
BMJ 2004 329: 282-284. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Lyle, K., Dent, L., Bailey, S., Kerridge, L., Roberts, I., Milne, R. (2009). Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials. BMJ 339: b4187-b4187 [Abstract] [Full text]  
• Duley, L., Antman, K., Arena, J., Avezum, A., Blumenthal, M., Bosch, J., Chrolavicius, S., Li, T., Ounpuu, S., Perez, A. C., Sleight, P., Svard, R., Temple, R., Tsouderous, Y., Yunis, C., Yusuf, S. (2008). Specific barriers to the conduct of randomized trials. Clin Trials 5: 40-48 [Abstract]  
• McMichael, A J, Friel, S, Nyong, A, Corvalan, C (2008). Global environmental change and health: impacts, inequalities, and the health sector. BMJ 336: 191-194 [Full text]  

Online poll

Find out more >>